Document is current

Any future updates will be listed below

Intravitreal Bevacizumab nanoparticles ameliorates retinal vasculopathy in an in vivo mouse model of retinopathy of prematurity

Crossref DOI link: https://doi.org/10.1038/s41390-025-04508-w

Published Online: 2025-10-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark